Thigpen, J Tate <br/><br/>
Role of pegylated liposomal doxorubicin in ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  Jan 2005 
 - 10-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2004.09.046  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibiotics, Antineoplastic--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Doxorubicin--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Ovarian Neoplasms--drug therapy<br/>Polyethylene Glycols--administration & dosage<br/>Randomized Controlled Trials as Topic